Treatment of Invasive Candidiasis in Immunocompromised Pediatric Patients

Author： Fisher Brian T.   Zaoutis Theoklis E.  

Publisher： Adis International

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.10, Iss.5, 2008-01, pp. : 281-298

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Select the appropriate treatment regimen to improve morbidity and mortality in immunocompromised paediatric patients with invasive candidiasis

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 25, Iss. 7, 2009-07 ,pp. : 10-12

Adis International

Access to resources Recommend Favorite

Current Strategies in the Treatment of Invasive Aspergillus Infections in Immunocompromised Patients

By Harari S.  

Drugs, Vol. 58, Iss. 4, 1999-10 ,pp. : 621-631

Adis International

Access to resources Recommend Favorite

Resource Utilization and Cost of Treatment with Anidulafungin or Fluconazole for Candidaemia and Other Forms of Invasive Candidiasis: Focus on Critically Ill Patients

By Reboli Annette C.  

PharmacoEconomics, Vol. 29, Iss. 8, 2011-08 ,pp. : 705-717

Adis International

Access to resources Recommend Favorite

Invasive Aspergillosis: Epidemiology, Diagnosis and Management in Immunocompromised Patients

By Maschmeyer Georg  

Drugs, Vol. 67, Iss. 11, 2007-01 ,pp. : 1567-1601

Adis International

Access to resources Recommend Favorite

Cytomegalovirus treatment options in immunocompromised patients

By Sharland Mike   Khare Milind D  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 8, 2001-08 ,pp. : 1247-1257

Informa Healthcare

Access to resources Recommend Favorite